Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
29.45
-0.29 (-0.98%)
At close: Aug 19, 2025, 3:59 PM
29.44
-0.03%
Pre-market: Aug 20, 2025, 08:22 AM EDT
Crinetics Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 53.73M | 94.57M | 264.55M | 317.27M | 302.16M | 395.92M | 54.9M | 142.79M | 39.55M | 41.19M | 32.67M | 30.91M | 62.29M | 145.55M | 200.69M | 161.54M | 178.77M | 105.58M |
Short-Term Investments | 1.14B | 1.18B | 1.09B | 545.4M | 560.79M | 505.04M | 503.66M | 411.86M | 224.98M | 254.93M | 301.75M | 337.45M | 346.21M | 174.18M | 133.01M | 31.79M | 24.99M | 45.09M |
Long-Term Investments | 800K | n/a | 2M | 1.3M | 2M | 1.3M | 1.77M | 4.67M | 1.97M | 1.97M | 1.97M | 1.4M | 346.21M | 568K | 1.01M | 500K | 500K | 500K |
Other Long-Term Assets | 14.94M | 14.95M | 1.63M | 2.51M | 1.5M | 2M | 2M | 3.3M | 2M | 2M | 37K | n/a | -345.61M | n/a | 568K | n/a | n/a | n/a |
Receivables | n/a | 7.31M | 8.47M | 7.03M | 5.1M | 9.44M | 9.35M | 11.64M | 11.82M | 2.35M | n/a | 2.35M | 2.11M | 1.54M | 2.03M | 1.04M | 1.04M | 857K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.64M | 15.14M | -2.35M | n/a | 5.96M | 4.04M | 5.36M | -2.03M | n/a | n/a | n/a |
Other Current Assets | 20.9M | 3.2M | 1.71M | 1.49M | 1.51M | 3.56M | 1.58M | 15.16M | 2.76M | n/a | 7.25M | 1.65M | 1.63M | 1.62M | n/a | n/a | n/a | n/a |
Total Current Assets | 1.22B | 1.29B | 1.38B | 877.59M | 874.78M | 917.23M | 574.15M | 575.76M | 284.81M | 305.4M | 345.18M | 378.32M | 416.29M | 328.25M | 344.72M | 203.97M | 211.35M | 157.8M |
Property-Plant & Equipment | 56.57M | 55.32M | 55.58M | 55.98M | 57.26M | 57.63M | 57.43M | 57.81M | 4.47M | 4.64M | 4.99M | 5.16M | 4.85M | 4.47M | 4.72M | 4.89M | 5.07M | 5.25M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 72.31M | 70.27M | 59.2M | 59.79M | 60.76M | 60.92M | 61.2M | 65.78M | 8.44M | 8.61M | 6.99M | 6.56M | 5.45M | 5.04M | 6.29M | 5.39M | 5.57M | 5.75M |
Total Assets | 1.29B | 1.36B | 1.43B | 937.37M | 935.53M | 978.15M | 635.35M | 641.54M | 293.25M | 314.01M | 352.18M | 384.88M | 421.73M | 333.29M | 351.01M | 209.36M | 216.93M | 163.55M |
Account Payables | 11.32M | 9.84M | 5.85M | 4.94M | 8.87M | 10.76M | 6.55M | 5.84M | 4.84M | 5.89M | 6.88M | 5.88M | 9.04M | 4.73M | 3.42M | 3.05M | 3.75M | 2.91M |
Deferred Revenue | 1.9M | 2.21M | 2.18M | 1.69M | 2.56M | 2.46M | 2.06M | 1.66M | 2.08M | 2.12M | 2.24M | 2.32M | 2.54M | 2.71M | -939K | -912K | -886K | -860K |
Short-Term Debt | 6.61M | n/a | n/a | n/a | n/a | 5.79M | 4.17M | 3.99M | 1.11M | 1.08M | n/a | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 48.56M | 16.61M | 10K | 26.19M | 20.38M | 12.13M | 12.47M | 12.1M | 14.87M | 9.32M | 8.47M | 6.7M | 9.09M | 8.37M | 93K | 912K | 886K | 860K |
Total Current Liabilities | 68.4M | 57.31M | 59.68M | 53.56M | 54.38M | 51.77M | 43.94M | 40.46M | 32.61M | 26.32M | 27.72M | 24.56M | 26.11M | 20.26M | 15.99M | 12.44M | 11.92M | 10.26M |
Long-Term Debt | 43.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.33M | 1.77M | 829K | 511K | 202K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 7K | 12K | 18K |
Total Long-Term Liabilities | 49.65M | 50.02M | 50.1M | 50.83M | 50.4M | 51.45M | 52.3M | 53.33M | 6.53M | 7.36M | 8.13M | 8.95M | 9.45M | 9.98M | 3.08M | 3.33M | 3.57M | 3.81M |
Total Liabilities | 118.05M | 107.33M | 109.79M | 104.39M | 104.77M | 103.22M | 96.25M | 93.79M | 39.14M | 33.68M | 35.85M | 33.51M | 35.57M | 30.24M | 19.07M | 15.77M | 15.49M | 14.07M |
Total Debt | 49.94M | 50.82M | 51.72M | 52.54M | 53.32M | 52.5M | 51.73M | 52.17M | 2.56M | 2.82M | 2.02M | 3.32M | 2.56M | 2.82M | 3.07M | 3.32M | 3.56M | 3.79M |
Common Stock | 2.33B | 2.3B | 2.28B | 1.7B | 1.63B | 1.6B | 1.19B | 1.14B | 791.97M | 768.01M | 759.43M | 750.56M | 742.04M | 615.12M | 607.58M | 438.06M | 418.04M | 339.98M |
Retained Earnings | -1.16B | -1.05B | -952.11M | -871.51M | -794.69M | -720.63M | -653.7M | -593.61M | -536.15M | -485.17M | -439.17M | -394.18M | -352.26M | -309.88M | -275.25M | -244.46M | -216.61M | -190.51M |
Comprehensive Income | 1.62M | 2M | 963K | 2.04M | -190K | 150K | 977K | -865K | -1.71M | -2.51M | -3.93M | -5.01M | -3.62M | -2.19M | -382K | -12K | 10K | 19K |
Shareholders Equity | 1.17B | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M | 539.11M | 547.75M | 254.12M | -485.17M | -439.17M | 351.37M | 386.17M | 303.04M | -275.25M | 193.59M | 201.44M | 149.48M |
Total Investments | 1.14B | 1.18B | 1.09B | 545.4M | 562.09M | 506.34M | 505.43M | 416.53M | 224.98M | 254.93M | 301.75M | 337.45M | 692.43M | 174.18M | 133.01M | 31.79M | 24.99M | 45.09M |